172 related articles for article (PubMed ID: 15182431)
21. Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia.
Shearer BM; Flynn HC; Knudson RA; Ketterling RP
Br J Haematol; 2005 Apr; 129(1):45-52. PubMed ID: 15801954
[TBL] [Abstract][Full Text] [Related]
22. Molecular investigation of 19p13 in standard and variant translocations: the E12 probe recognizes the 19p13 breakpoint in cases with t(1;19) and acute leukemia other than pre-B immunophenotype.
Yamada T; Craig JM; Hawkins JM; Janossy G; Secker-Walker LM
Leukemia; 1991 Jan; 5(1):36-40. PubMed ID: 1999956
[TBL] [Abstract][Full Text] [Related]
23. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
24. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study.
Borowitz MJ; Hunger SP; Carroll AJ; Shuster JJ; Pullen DJ; Steuber CP; Cleary ML
Blood; 1993 Aug; 82(4):1086-91. PubMed ID: 8353275
[TBL] [Abstract][Full Text] [Related]
25. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.
Wiemels JL; Leonard BC; Wang Y; Segal MR; Hunger SP; Smith MT; Crouse V; Ma X; Buffler PA; Pine SR
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15101-6. PubMed ID: 12415113
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular characteristics of
Ohki K; Kiyokawa N; Saito Y; Hirabayashi S; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fukushima K; Hasegawa D; Fukushima H; Imai M; Kajiwara R; Koike T; Komori I; Matsui A; Mori M; Moriwaki K; Noguchi Y; Park MJ; Ueda T; Yamamoto S; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Takahashi H; Fukushima T; Hayashi Y; Koh K; Manabe A; Ohara A;
Haematologica; 2019 Jan; 104(1):128-137. PubMed ID: 30171027
[TBL] [Abstract][Full Text] [Related]
27. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
Deucher AM; Qi Z; Yu J; George TI; Etzell JE
Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of the t(1;19) breakpoint cluster region in pre-B cell acute lymphoblastic leukemias.
Mellentin JD; Nourse J; Hunger SP; Smith SD; Cleary ML
Genes Chromosomes Cancer; 1990 Sep; 2(3):239-47. PubMed ID: 2078515
[TBL] [Abstract][Full Text] [Related]
29. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.
Mellentin JD; Murre C; Donlon TA; McCaw PS; Smith SD; Carroll AJ; McDonald ME; Baltimore D; Cleary ML
Science; 1989 Oct; 246(4928):379-82. PubMed ID: 2799390
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations.
Sotomatsu M; Hayashi Y; Kawamura M; Yugami S; Shitara T
Leukemia; 1993 Oct; 7(10):1615-20. PubMed ID: 8412323
[TBL] [Abstract][Full Text] [Related]
31. [Childhood acute lymphoblastic leukemia with t(1;19) lacking E2A-pBX1 chimeric transcripts].
Matsubara K; Hirata T
Rinsho Ketsueki; 2005 Jan; 46(1):7-12. PubMed ID: 16708911
[TBL] [Abstract][Full Text] [Related]
32. [Acute T cells lymphoblastic leukemia with a t(1;19)(q23;p13) and E2A-PBX1 in an adult: one case report and literature review].
He GS; Zhang XH; Yao L; Zhang R; Chen ZX; Wu DP; Sun AN; Jin ZM; Qiu HY; Hu XH
Zhonghua Xue Ye Xue Za Zhi; 2009 Oct; 30(10):675-7. PubMed ID: 19954663
[TBL] [Abstract][Full Text] [Related]
33. Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature.
Hunger SP; Sun T; Boswell AF; Carroll AJ; McGavran L
Genes Chromosomes Cancer; 1997 Dec; 20(4):392-8. PubMed ID: 9408756
[TBL] [Abstract][Full Text] [Related]
34. t(1;19) without detectable E2A rearrangements in two t(14;18)-positive lymphoma/leukemia cases.
Wlodarska I; Stul M; De Wolf-Peeters C; Verhoef G; Mecucci C; Cassiman JJ; Van den Berghe H
Genes Chromosomes Cancer; 1994 Jul; 10(3):171-6. PubMed ID: 7522039
[TBL] [Abstract][Full Text] [Related]
35. Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes.
Devaraj PE; Foroni L; Janossy G; Hoffbrand AV; Secker-Walker LM
Leukemia; 1995 May; 9(5):821-5. PubMed ID: 7769844
[TBL] [Abstract][Full Text] [Related]
36. Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis.
Yilmaz M; Kantarjian HM; Toruner G; Yin CC; Kanagal-Shamanna R; Cortes JE; Issa G; Short NJ; Khoury JD; Garcia-Manero G; Ravandi F; Kadia T; Konopleva M; Wierda WG; Jain N; Estrov Z; Sasaki K; Pierce S; O'Brien SM; Jabbour EJ
Leuk Lymphoma; 2021 Jan; 62(1):224-228. PubMed ID: 32955970
[TBL] [Abstract][Full Text] [Related]
37. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
[TBL] [Abstract][Full Text] [Related]
38. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses.
Izraeli S; Janssen JW; Haas OA; Harbott J; Brok-Simoni F; Walther JU; Kovar H; Henn T; Ludwig WD; Reiter A
Leukemia; 1993 May; 7(5):671-8. PubMed ID: 8483319
[TBL] [Abstract][Full Text] [Related]
39. Acute lymphoblastic leukemia associated with a t(1;19)(q23;p13) in an adult.
Ohno H; Inoue T; Akasaka T; Okumura A; Miyanishi S; Ohashi I; Kikuchi M; Masuya M; Amano H; Imanaka T
Intern Med; 1993 Jul; 32(7):584-7. PubMed ID: 8286840
[TBL] [Abstract][Full Text] [Related]
40. Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells.
Berendes P; Hoogeveen A; van Dijk M; van Denderen J; van Ewijk W
Leukemia; 1995 Aug; 9(8):1321-7. PubMed ID: 7643619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
